varenicline tartrate 0.5 mg

1 INDICATIONS AND USAGE Varenicline tablets are indicated for use as an aid to smoking cessation treatment. Varenicline is a nicotinic receptor partial agonist indicated for use as an aid to smoking cessation treatment. ( 1 and 2.1 )

par pharmaceutical, inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] diarrhoea` `[4] fatigue` `[5] off label use` `[6] dyspnoea` `[7] acute kidney injury` `[8] pyrexia` `[9] death` `[10] renal failure`

2 years ago

ROUND WHITE P 155

16 HOW SUPPLIED/STORAGE AND HANDLING Varenicline tablets are supplied for oral administration in two strengths: a 0.5 mg circular, biconvex, white to off-white film-coated tablets, debossed with “P” on one side and “155” on other side and a 1 mg circular, biconvex, light blue film-coated tablets, debossed with “P” on one side and “156” on other side. Varenicline tablets are supplied in the following package configurations: Description NDC Packs Starting 4-week card: 0.5 mg x 11 tablets and 1 mg x 42 tablets NDC 49884-944-99 Starting Month Box: 0.5 mg x 11 tablets and 1 mg x 42 tablets NDC 49884-944-99 Continuing 4-week card: 1 mg x 56 tablets NDC 49884-156-52 Continuing Month Box: 1 mg x 56 tablets NDC 49884-156-52 Bottles 0.5 mg - bottle of 56 NDC 49884-155-76 1 mg - bottle of 56 NDC 49884-156-76 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

More pills like ROUND P 155

Related Pills

varenicline tartrate 1 mg

par pharmaceutical, inc.

Hydrochlorothiazide 12.5 MG Oral Tablet

leading pharma, llc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site